2
icotec AG Received FDA Clearance to Market BlackArmor® Carbon/PEEK Interbody Cages
mehr
Neueste Storys
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Grünenthal Initiates Pivotal Phase III Trials in Complex Regional Pain Syndrome
Aachen, Germany (ots) - Grünenthal announced today that first patients have been enrolled in two trials of the company's pivotal phase III program investigating neridronate for the treatment of Complex Regional Pain Syndrome (CRPS). These two trials, KF7013-02 and KF7013-04, are investigating the efficacy and safety of neridronate in 360 patients with CRPS. ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Cancer: More targeted use of immunotherapy
Doctors are increasingly fighting cancer by stimulating patients' immune systems. SNSF-supported researchers have now discovered a method for predicting the likelihood of treatment success. Immunotherapy changes a patient's immune system to allow it to attack cancer cells and either destroy them or at least keep them from growing. ...
mehrEQS-Adhoc: AEVIS VICTORIA SA issues bonds of CHF 45 million
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Bond AEVIS VICTORIA SA issues bonds of CHF 45 million 11-Jun-2018 / 19:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. 694349 11-Jun-2018 CET/CEST ...
mehrDelta-Q Technologies Releases New 85V and 120V Industrial Lithium Battery Chargers to Meet Market Demand
Vancouver, British Columbia (ots/PRNewswire) - Delta-Q Technologies (http://www.delta-q.com/) (Delta-Q), a leader in battery charging solutions for electric drive vehicles and machines, announced the release of four new high frequency lithium battery chargers in the ICL Series - the ICL1200 ...
mehrJanssen to Showcase New Data Across Broad Rheumatology Portfolio and Immunology Pipeline at EULAR 2018
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE ONLY The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that ten company-sponsored abstracts will be presented at the Annual European Congress of Rheumatology (EULAR 2018) in Amsterdam, Netherlands being held on 13-16 June. Data from the ...
mehr
The House of Givenchy Dresses Beyoncé and Jay-Z for Their Joint 'On the Run II' Tour
Paris (ots/PRNewswire) - The House of Givenchy is pleased to announce its collaboration with Beyoncé and Jay-Z for their 2018 On the Run II Tour costumes. To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8345751-givenchy-dresses-beyonce-jay-z-run-tour/ This event comes as a follow-up collaboration with the power couple; the ...
mehrEQS-Adhoc: AEVIS VICTORIA SA sold its stake in BioTelemetry, thus realising a total capital gain of CHF 14.3 million on its investment in LifeWatch
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Disposal AEVIS VICTORIA SA sold its stake in BioTelemetry, thus realising a total capital gain of CHF 14.3 million on its investment in LifeWatch 08-Jun-2018 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible ...
mehrEQS-News: SANDPIPER: Invitation to the annual general meeting and change in the Board of Directors
EQS Group-News: Sandpiper Digital Payments AG / Key word(s): AGM/EGM/Change of Personnel SANDPIPER: Invitation to the annual general meeting and change in the Board of Directors 07.06.2018 / 18:00 693533 07.06.2018 ...
mehrDGAP-News: EDAG Engineering Group AG: EDAG supports BYTON in the development of the 'Next-Generation smart device'
DGAP-News: EDAG Engineering Group AG / Key word(s): Incoming Orders EDAG Engineering Group AG: EDAG supports BYTON in the development of the 'Next-Generation smart device' (news with additional features) 07.06.2018 / 08:30 The issuer is solely responsible for the content of this announcement. ...
mehrEQS-Adhoc: Leclanché SA: Leclanché shareholders approve all Board proposals at Annual General Meeting
EQS Group-Ad-hoc: Leclanché SA / Key word(s): AGM/EGM/AGM/EGM Leclanché SA: Leclanché shareholders approve all Board proposals at Annual General Meeting 07-Jun-2018 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. ...
mehrNew UCB Data Presented at the Annual European Congress of Rheumatology (EULAR 2018) Serves Key Patient Populations Including Ankylosing Spondylitis, Psoriatic Arthritis, and Women with Chronic Inflammatory Diseases
Brussels (ots/PRNewswire) - - Late-breaking oral presentation on bimekizumab shows significant potential for treating ankylosing spondylitis (AS) - Oral presentation on CIMZIA® (certolizumab pegol) pregnancy outcomes shows no increased risk of major congenital malformations compared to the general population nor an ...
mehr
EQS-Adhoc: Airopack Technology Group AG: Boldking foaming shave gel powered by Airopack's planet friendly aerosol
EQS Group-Ad-hoc: Airopack Technology Group AG / Key word(s): Product Launch/Development of Sales Airopack Technology Group AG: Boldking foaming shave gel powered by Airopack's planet friendly aerosol 07-Jun-2018 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely ...
mehrFemale Leaders Embrace Disruption, Trust Data and are Realistic About Future Growth: KPMG International
Berlin (ots/PRNewswire) - - 77 percent see technological disruption as more of an opportunity than a threat. - 58 percent have made strategic decisions based on data-driven insights - rather than overlooking the data based on intuition. - 77 percent are confident about the growth potential for their company. - But only 28 percent see their next career step within their ...
mehrDGAP-News: LION E-Mobility AG: LION Smart GmbH signs development contract for battery platform
DGAP-News: LION E-Mobility AG / Key word(s): Contract LION E-Mobility AG: LION Smart GmbH signs development contract for battery platform 06.06.2018 / 10:15 The issuer is solely responsible for the content of this announcement. 692845 06.06.2018 ...
mehrEANS-News: voestalpine AG / voestalpine Group revenue and earnings at an all-time-high
issuer: voestalpine AG voestalpine-Straße 1 A-4020 Linz phone: +43 50304/15-9949 FAX: +43 50304/55-5581 mail: IR@voestalpine.com WWW: www.voestalpine.com ISIN: AT0000937503 indexes: ATX, WBI stockmarkets: Wien language: English ...
mehrEQS-Adhoc: Leclanché SA: Leclanché announces a CHF 16.5 million share capital increase
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Funds/Investment Leclanché SA: Leclanché announces a CHF 16.5 million share capital increase 06-Jun-2018 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. 692751 06-Jun-2018 CET/CEST ...
mehrOrascom Development Holding AG
EQS-Adhoc: Orascom Development Holding AG:Turnaround Strategy Bearing Its Fruits with Significant Increase on the Operational and Financial Level across all Segments. Revenues grew by 41.1% to CHF 74.1 million, Adjusted EBITDA Increased By 206.3% to C...
EQS Group-Ad-hoc: Orascom Development Holding AG / Key word(s): Interim Report/Interim Report Orascom Development Holding AG:Turnaround Strategy Bearing Its Fruits with Significant Increase on the Operational and Financial Level across all Segments. Revenues grew by 41.1% to CHF 74.1 million, Adjusted EBITDA ...
mehr
DGAP-News: LION E-Mobility AG: New battery concept 'Light Battery' - modular, safe and wireless
DGAP-News: LION E-Mobility AG / Key word(s): Product Launch/Interim Report LION E-Mobility AG: New battery concept 'Light Battery' - modular, safe and wireless 05.06.2018 / 14:19 The issuer is solely responsible for the content of this announcement. 692467 05.06.2018 ...
mehrIMI-PainCare: Public-private partnership tackles major challenges in the care of pain patients
Aachen (ots) - To improve the care of patients with acute or chronic pain, a consortium from academia, small and medium-sized enterprises (SMEs), pain societies, patient organizations and pharmaceutical industry launched the research project "IMI-PainCare - Improving the care of patients suffering from acute or ...
mehrEANS-Adhoc: voestalpine AG/Dr. Wolfgang Eder, Chairman of the Management Board of voestalpine AG, resigns from office with effect from the 2019 AGM; Supervisory Board appoints DI Herbert Eibensteiner as successor
issuer: voestalpine AG voestalpine-Straße 1 A-4020 Linz phone: +43 50304/15-9949 FAX: +43 50304/55-5581 mail: IR@voestalpine.com WWW: www.voestalpine.com ISIN: AT0000937503 indexes: WBI, ATX stockmarkets: Wien language: English ...
mehrAtrium European Real Estate Limited
EANS-Adhoc: ATRIUM EUROPEAN REAL ESTATE LIMITED ANNOUNCES POSTPONEMENT OF PRICING FOR THE TENDER OFFERS
issuer: Atrium European Real Estate Limited Seaton Place 11-15 UK-JE4 0QH St Helier Jersey / Channel Islands phone: +44 (0)20 7831 3113 FAX: mail: richard.sunderland@fticonsulting.com WWW: http://www.aere.com ISIN: JE00B3DCF752 indexes: stockmarkets: Wien, Luxembourg Stock Exchange language: English ...
mehrEQS-Adhoc: Leclanché SA: Leclanché secures funding of CHF 75 million, and an additional CHF 50 million facility to finance acquisitions and joint ventures in the fast-growing e-Transport and stationary grid-based storage markets
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Funds/Investment Leclanché SA: Leclanché secures funding of CHF 75 million, and an additional CHF 50 million facility to finance acquisitions and joint ventures in the fast-growing e-Transport and stationary grid-based storage markets 05-Jun-2018 / 07:00 CET/CEST ...
mehrEQS-Adhoc: SANDPIPER Digital Payments AG releases audited 2017 financial statement
EQS Group-Ad-hoc: Sandpiper Digital Payments AG / Key word(s): Final Results SANDPIPER Digital Payments AG releases audited 2017 financial statement 04-Jun-2018 / 20:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 18 KR The issuer is solely responsible for the content of this announcement. 692209 04-Jun-2018 CET/CEST ...
mehr
EANS-Adhoc: ams AG / ams has published the proposals for the Annual General Meeting on 6 June 2018
issuer: ams AG Tobelbader Strasse 30 A-8141 Premstaetten phone: +43 3136 500-0 FAX: +43 3136 500-931211 mail: investor@ams.com WWW: www.ams.com ISIN: AT0000A18XM4 indexes: stockmarkets: SIX Swiss Exchange language: English ...
mehrMerck Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018
Darmstadt, Germany (ots/PRNewswire) - ASCO Abstract # M7824 (TGF-ß trap/anti-PD-L1): 3007, 9017, 2566, TPS3130; Tepotinib (c-Met kinase inhibitor): 9082, 9016; M2698 (dual p70S6k/Akt inhibitor): 2584; M6620 (ATR inhibitor): 2549; M3814 (DNA-PK): 2518 Not intended for UK- or US-based media - M7824 is an investigational immunotherapy that is designed to bring together ...
mehrHitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe wins the contract to supply 6 ultrasound systems in the UK helping to improve prostate cancer diagnosis ...
Zug, Switzerland (ots) - Hitachi Medical Systems Europe wins the contract to supply 6 ultrasound systems in the UK helping to improve prostate cancer diagnosis as part of the innovative RAPID programme at three major hospitals across South West London The new RAPID (Rapid Assessment Prostate Imaging and Diagnosis) ...
mehrTwo Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with BAVENCIO® (avelumab)
Chicago (ots/PRNewswire) - Not intended for US, Canada and UK-based media - Two-year follow-up data on meaningful durable response, overall survival (OS) and progression-free survival (PFS) to be presented in patients with metastatic Merkel cell carcinoma (mMCC), a rare and aggressive type of skin cancer Merck and ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Hybrid overhead lines: More power, not more power lines
Social opposition to new high-voltage lines is delaying modernisation of the power grid. Two projects of the National Research Programmes "Energy Turnaround" and "Managing Energy Consumption" have determined the optimum design of hybrid overhead lines needed to increase the capacity of the power transmission grid and, at the same time, win popular acceptance for the new technology. Unlike conventional power lines, hybrid ...
mehrMerck Presents Update on Tepotinib in Advanced Lung Cancer at ASCO 2018
Darmstadt, Germany (ots/PRNewswire) - ASCO Abstract # Tepotinib (c-Met kinase inhibitor): 9082, 9016; M7824 (TGF-ß trap/anti-PD-L1): 3007, 9017, 2566; M2698 (dual p70S6k/Akt inhibitor): 2584; M6620 (ATR inhibitor): 2549; M3814 (DNA-PK): 2518 Not intended for UK- or US-based media - Data from an ongoing Phase II tepotinib study show anti-tumor clinical activity in ...
mehr
Vorherige158159160161162163164165166167Nächste